{"product_id":"krmd-ansoff-analysis","title":"(KRMD) KORU Medical Systems, Inc. ANSOFF Analysis Research","description":"\u003cdiv class=\"pr-shrt-dscr-wrapper\"\u003e\n\u003csection class=\"pr-shrt-dscr-box\"\u003e\n\u003cdiv class=\"pr-shrt-dscr-icon\"\u003e\n\u003cimg src=\"\/cdn\/shop\/files\/GENERAL-List-Icon.svg\" alt=\"Icon\"\u003e\n\u003ch3\u003eUnlock the Full Ansoff Matrix for Deeper Strategic Insight\u003c\/h3\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"pr-shrt-dscr-content\"\u003e\n\u003cp\u003eThis KORU Medical Systems, Inc. Ansoff Matrix Analysis helps you quickly assess growth options across market penetration, market development, product development, and diversification in one clear framework; the page includes a real preview\/sample so you can judge style and substance before buying. Purchase the full version to get the complete, ready-to-use analysis for strategy, research, or investment work.\u003c\/p\u003e\n\u003c\/div\u003e\n\u003c\/section\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"pr-shrt-dscr-wrapper\"\u003e\n\u003cdiv class=\"container_new_design pr-shrt-dscr-box\"\u003e\n\u003cdiv class=\"text-section text-1_new_design\"\u003e\n\u003cdiv class=\"sub-highlight-wrapper_heading\"\u003e\n\u003cimg src=\"\/cdn\/shop\/files\/ANSOFF-Content-Market-Penetration-Icon-1.svg\" alt=\"Icon\"\u003e\n\u003ch2\u003eMarket Penetration\u003c\/h2\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"sub-highlight-wrapper\"\u003e\n\u003csection class=\"sub-highlight-box\"\u003e\n\u003cdiv class=\"sub-highlight-icon\"\u003e\n\u003cimg src=\"\/cdn\/shop\/files\/GENERAL-Checkmark-Icon.svg\" alt=\"Icon\"\u003e\n\u003ch3\u003eFREEDOM60 installed-base growth in the U.S. ambulatory infusion market\u003c\/h3\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"sub-highlight-content\"\u003e\n\u003cp\u003eFREEDOM60 installed-base growth in the U.S. ambulatory infusion market is a share-gain play: KORU Medical Systems sells more systems into a market it already serves, not a new one. Its portable, elastomeric design supports repeat use in home and ambulatory infusion, where therapy education can lift conversion and retention. With U.S. home infusion demand still rising, more installed systems can drive higher recurring consumables and replacement demand.\u003c\/p\u003e\n\u003c\/div\u003e\n\u003c\/section\u003e\n\u003csection class=\"sub-highlight-box\"\u003e\n\u003cdiv class=\"sub-highlight-icon\"\u003e\n\u003cimg src=\"\/cdn\/shop\/files\/GENERAL-Checkmark-Icon.svg\" alt=\"Icon\"\u003e\n\u003ch3\u003eFreedomEdge account expansion through direct sales\u003c\/h3\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"sub-highlight-content\"\u003e\n\u003cp\u003eFreedomEdge account expansion through direct sales fits KORU Medical Systems, Inc.’s market penetration play because it deepens use in accounts already buying mechanical infusion solutions. FreedomEdge remains part of the FREEDOM infusion systems portfolio, so direct coverage can protect and grow recurring provider relationships. KORU Medical Systems, Inc. reported about $31 million in annual revenue recently, so even small account gains can matter.\u003c\/p\u003e\n\u003c\/div\u003e\n\u003c\/section\u003e\n\u003c\/div\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"image-section image-1_new_design\"\u003e\n\u003cimg src=\"\/cdn\/shop\/files\/ANSOFF-Content-Market-Penetration-Image.png\" alt=\"Explore a Preview\"\u003e\n\u003c\/div\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"sub-highlight-box-border\"\u003e\n\u003csection class=\"sub-highlight-box\"\u003e\n\u003cdiv class=\"sub-highlight-icon\"\u003e\n\u003cimg src=\"\/cdn\/shop\/files\/GENERAL-Checkmark-Icon.svg\" alt=\"Icon\"\u003e\n\u003ch3\u003eHIgH-Flo needle set pull-through\u003c\/h3\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"sub-highlight-content\"\u003e\n\u003cp\u003eHIgH-Flo needle set pull-through is a classic market penetration play for KORU Medical Systems, Inc. It lifts share by tying recurring consumable sales to the installed infusion base, so each new system can keep generating repeat orders. HIgH-Flo subcutaneous safety needle sets are already in the portfolio, which supports same-customer revenue growth without entering a new market.\u003c\/p\u003e\n\u003c\/div\u003e\n\u003c\/section\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"product-green-section\"\u003e\n\u003cdiv class=\"product-box-green-section4\"\u003e\n\u003cdiv class=\"title-row-green-section\"\u003e\n\u003ch3\u003ePrecision flow rate tubing reorder growth\u003c\/h3\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"content-row-green-section blur_box\"\u003e\n\u003cp\u003ePrecision flow rate tubing reorder growth is classic market penetration for KORU Medical Systems, Inc. It drives repeat buying from existing FREEDOM system users in ambulatory infusion, where the installed base already uses the tubing as a consumable. In 2025, KORU’s annual revenue was centered on the same core ecosystem, so higher refill frequency should lift same-market sales.\u003c\/p\u003e\n\u003cul class=\"lst_crct\"\u003e\n\u003cli\u003eRepeat use from current patients\u003c\/li\u003e\n\u003cli\u003eSupports FREEDOM system sales\u003c\/li\u003e\n\u003cli\u003eExpands share in ambulatory infusion\u003c\/li\u003e\n\u003c\/ul\u003e\n\u003cp\u003eBecause tubing is replaced regularly, even small reorder gains can raise revenue without needing new market entry. That makes this a low-risk growth lever inside KORU Medical Systems, Inc.'s current customer base.\u003c\/p\u003e\n\u003c\/div\u003e\n\u003cbutton class=\"get_full_prdct_green\" onclick=\"get_full()\"\u003e\u003c\/button\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"product-box-green-section4\"\u003e\n\u003cdiv class=\"title-row-green-section\"\u003e\n\u003ch3\u003eDistributor and online channel share capture\u003c\/h3\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"content-row-green-section blur_box\"\u003e\n\u003cp\u003eKORU Medical Systems, Inc. can capture more share in current markets by pushing the same patient base through two active routes: medical device distributors and online channels. That widens access without changing the core product, so order frequency can rise inside the same customer set. In Ansoff terms, this is market penetration, not new-market expansion.\u003c\/p\u003e\n\u003cul class=\"lst_crct\"\u003e\n\u003cli\u003eUses existing distributor network\u003c\/li\u003e\n\u003cli\u003eExpands reach through online orders\u003c\/li\u003e\n\u003cli\u003eTargets the same customer base\u003c\/li\u003e\n\u003cli\u003eLifts volume without new products\u003c\/li\u003e\n\u003c\/ul\u003e\n\u003c\/div\u003e\n\u003cbutton class=\"get_full_prdct_green\" onclick=\"get_full()\"\u003e\u003c\/button\u003e\n\u003c\/div\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"sub-highlight-box-border\"\u003e\n\u003csection class=\"highlight-box\"\u003e\n\u003cdiv class=\"highlight-icon\"\u003e\n\u003cimg src=\"\/cdn\/shop\/files\/GENERAL-Checkmark-Icon.svg\" alt=\"Icon\"\u003e\n\u003ch3\u003eKORU Grows by Selling More Into the Same Market\u003c\/h3\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"highlight-content\"\u003e\n\u003cp\u003eKORU Medical Systems, Inc.’s market penetration is driven by more FREEDOM60 and FreedomEdge use in the same ambulatory infusion market, plus higher repeat orders for HIgH-Flo needle sets and precision flow tubing. That fits 2025\/2026 same-market growth, with about $31 million in annual revenue. More installed systems can lift consumables and replacements without new market entry.\u003c\/p\u003e\n\u003ctable class=\"tbl_prdct green_head blur_tbl\"\u003e\n\u003cthead\u003e\u003ctr\u003e\n\u003cth\u003eDriver\u003c\/th\u003e\n\u003cth\u003eType\u003c\/th\u003e\n\u003cth\u003eEffect\u003c\/th\u003e\n\u003c\/tr\u003e\u003c\/thead\u003e\n\u003ctbody\u003e\n\u003ctr\u003e\n\u003ctd\u003eFREEDOM60\u003c\/td\u003e\n\u003ctd\u003eInstalled base\u003c\/td\u003e\n\u003ctd\u003eShare gain\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003ctr\u003e\n\u003ctd\u003eHIgH-Flo\u003c\/td\u003e\n\u003ctd\u003eConsumable\u003c\/td\u003e\n\u003ctd\u003eReorder lift\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003ctr\u003e\n\u003ctd\u003eDirect sales\u003c\/td\u003e\n\u003ctd\u003eChannel\u003c\/td\u003e\n\u003ctd\u003eSame market reach\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003c\/tbody\u003e\n\u003c\/table\u003e\n\u003cbutton class=\"get_full_prdct_green\" onclick=\"get_full()\"\u003e\u003c\/button\u003e\n\u003c\/div\u003e\n\u003c\/section\u003e\n\u003c\/div\u003e\n\u003c\/div\u003e\n\u003csection class=\"product-includes\"\u003e\n\u003cdiv class=\"product-includes__container\"\u003e\n\u003ch2 id=\"product-includes-title\" class=\"product-includes__title\"\u003eWhat is included in the product\u003c\/h2\u003e\n\u003cdiv class=\"product-includes__grid\"\u003e\n\u003cdiv class=\"include-card\"\u003e\n\u003cdiv class=\"include-card__icon-wrap\"\u003e\n\u003cimg class=\"include-card__icon\" src=\"\/cdn\/shop\/files\/GENERAL-Word-Icon.svg\" alt=\"Detailed Word Document icon\"\u003e\n\u003c\/div\u003e\n\u003ch3 class=\"include-card__heading\"\u003e\u003cstrong\u003eDetailed Word Document\u003c\/strong\u003e\u003c\/h3\u003e\n\u003cp class=\"include-card__text\"\u003eProvides a clear Ansoff Matrix framework for analyzing KORU Medical Systems, Inc.’s growth strategy across current and new markets and products\u003c\/p\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"include-card\"\u003e\n\u003cdiv class=\"include-card__icon-wrap\"\u003e\n\u003cimg class=\"include-card__icon\" src=\"\/cdn\/shop\/files\/GENERAL-Excel-Icon.svg\" alt=\"Customizable Excel Spreadsheet icon\"\u003e\n\u003c\/div\u003e\n\u003ch3 class=\"include-card__heading\"\u003e\u003cstrong\u003eEditable Excel File\u003c\/strong\u003e\u003c\/h3\u003e\n\u003cp class=\"include-card__text\"\u003eProvides a quick Ansoff view for KORU Medical Systems, Inc. to clarify growth options and reduce strategy guesswork.\u003c\/p\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"include-card\"\u003e\n\u003cdiv class=\"include-card__icon-wrap\"\u003e\n\u003cimg class=\"include-card__icon\" src=\"\/cdn\/shop\/files\/GENERAL-Reference-Icon.svg\" alt=\"References icon\"\u003e\n\u003c\/div\u003e\n\u003ch3 class=\"include-card__heading\"\u003e\u003cstrong\u003eReference Sources\u003c\/strong\u003e\u003c\/h3\u003e\n\u003cp class=\"include-card__text\"\u003eProvides a concise, traceable bibliography of primary and reputable sources validating KORU Medical Systems’ Ansoff Matrix assumptions for fast due diligence.\u003c\/p\u003e\n\u003c\/div\u003e\n\u003c\/div\u003e\n\u003c\/div\u003e\n\u003c\/section\u003e\n\u003cdiv class=\"pr-shrt-dscr-wrapper\"\u003e\n\u003cdiv class=\"container_new_design pr-shrt-dscr-box\"\u003e\n\u003cdiv class=\"text-section text-2_new_design\"\u003e\n\u003cdiv class=\"sub-highlight-wrapper_heading\"\u003e\n\u003cimg src=\"\/cdn\/shop\/files\/ANSOFF-Content-Market-Development-Icon-1.svg\" alt=\"Icon\"\u003e\n\u003ch2\u003eMarket Development\u003c\/h2\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"sub-highlight-wrapper\"\u003e\n\u003csection class=\"sub-highlight-box\"\u003e\n\u003cdiv class=\"sub-highlight-icon\"\u003e\n\u003cimg src=\"\/cdn\/shop\/files\/GENERAL-Checkmark-Icon.svg\" alt=\"Icon\"\u003e\n\u003ch3\u003eInternational territory expansion for FREEDOM systems\u003c\/h3\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"sub-highlight-content\"\u003e\n\u003cp\u003eKORU Medical Systems’ international territory expansion uses existing FREEDOM60 and FreedomEdge systems to sell the same home-infusion platform in more markets outside the U.S., so this is geographic growth, not product redesign. The move builds on KORU Medical’s already global footprint and fits an Ansoff Market Development play, where international demand can rise without adding new core hardware.\u003c\/p\u003e\n\u003c\/div\u003e\n\u003c\/section\u003e\n\u003csection class=\"sub-highlight-box\"\u003e\n\u003cdiv class=\"sub-highlight-icon\"\u003e\n\u003cimg src=\"\/cdn\/shop\/files\/GENERAL-Checkmark-Icon.svg\" alt=\"Icon\"\u003e\n\u003ch3\u003eDistributor-led entry into additional countries\u003c\/h3\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"sub-highlight-content\"\u003e\n\u003cp\u003eKORU Medical Systems, Inc. can use distributor-led entry to push current infusion products into more countries without building a full local sales force. The company already sells through partners, so this model fits its cross-border setup and keeps market entry costs lower. For medical devices, distributor coverage is usually the fastest route to reach new geographies and scale existing products.\u003c\/p\u003e\n\u003c\/div\u003e\n\u003c\/section\u003e\n\u003c\/div\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"image-section image-2_new_design\"\u003e\n\u003cimg src=\"\/cdn\/shop\/files\/ANSOFF-Content-Market-Development-Image.png\" alt=\"Explore a Preview\"\u003e\n\u003c\/div\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"sub-highlight-box-border\"\u003e\n\u003csection class=\"sub-highlight-box\"\u003e\n\u003cdiv class=\"sub-highlight-icon\"\u003e\n\u003cimg src=\"\/cdn\/shop\/files\/GENERAL-Checkmark-Icon.svg\" alt=\"Icon\"\u003e\n\u003ch3\u003eOnline channel reach beyond the core U.S. base\u003c\/h3\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"sub-highlight-content\"\u003e\n\u003cp\u003eThis is market development because KORU Medical Systems, Inc. is extending an existing online channel into new geographies and buyer groups, not changing the product. In 2025, that kind of web-led ordering can support smaller international accounts and repeat buyers with lower sales-touch cost. It helps KORU Medical Systems, Inc. push beyond its core U.S. base faster.\u003c\/p\u003e\n\u003c\/div\u003e\n\u003c\/section\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"product-green-section\"\u003e\n\u003cdiv class=\"product-box-green-section4\"\u003e\n\u003cdiv class=\"title-row-green-section\"\u003e\n\u003ch3\u003eTraining materials localized for new regions\u003c\/h3\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"content-row-green-section blur_box\"\u003e\n\u003cp\u003eLocalized training materials help KORU Medical Systems, Inc. enter new markets with its current products by cutting adoption friction. KORU Medical Systems already gives education to healthcare professionals, patients, and patient advocates, so translating and adapting that content can speed uptake of the same infusion systems in new territories.\u003c\/p\u003e\n\u003cul class=\"lst_crct\"\u003e\n\u003cli\u003eLower onboarding friction\u003c\/li\u003e\n\u003cli\u003eSupport faster market entry\u003c\/li\u003e\n\u003cli\u003eReuse existing education assets\u003c\/li\u003e\n\u003cli\u003eImprove user confidence locally\u003c\/li\u003e\n\u003c\/ul\u003e\n\u003c\/div\u003e\n\u003cbutton class=\"get_full_prdct_green\" onclick=\"get_full()\"\u003e\u003c\/button\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"product-box-green-section4\"\u003e\n\u003cdiv class=\"title-row-green-section\"\u003e\n\u003ch3\u003eBroader ambulatory infusion provider coverage\u003c\/h3\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"content-row-green-section blur_box\"\u003e\n\u003cp\u003eBroader ambulatory infusion provider coverage is a market-development move: KORU Medical Systems, Inc. is selling the same systems into more provider accounts, not changing the therapy itself. That can raise volume faster because each new ambulatory infusion provider expands reach across the same subcutaneous and IV use cases.\u003c\/p\u003e\n\u003cp\u003eIt fits a low-change, lower-risk path: existing products stay in place, while the addressable customer map widens across clinics, home-infusion groups, and regional providers. The upside is better penetration of the ambulatory infusion base; the limit is that growth depends on winning more accounts, not on new therapy demand.\u003c\/p\u003e\n\u003cul class=\"lst_crct\"\u003e\n\u003cli\u003eNew provider accounts, same therapy category.\u003c\/li\u003e\n\u003cli\u003eBroader reach without product redesign.\u003c\/li\u003e\n\u003cli\u003eGrowth comes from more locations served.\u003c\/li\u003e\n\u003cli\u003eDepends on sales coverage and provider adoption.\u003c\/li\u003e\n\u003c\/ul\u003e\n\u003c\/div\u003e\n\u003cbutton class=\"get_full_prdct_green\" onclick=\"get_full()\"\u003e\u003c\/button\u003e\n\u003c\/div\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"sub-highlight-box-border\"\u003e\n\u003csection class=\"highlight-box\"\u003e\n\u003cdiv class=\"highlight-icon\"\u003e\n\u003cimg src=\"\/cdn\/shop\/files\/GENERAL-Checkmark-Icon.svg\" alt=\"Icon\"\u003e\n\u003ch3\u003eKORU Expands Reach with Low-Capex Market Development\u003c\/h3\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"highlight-content\"\u003e\n\u003cp\u003eKORU Medical Systems, Inc. is using Market Development by pushing FREEDOM60 and FreedomEdge into more geographies through distributors and web ordering, so the product stays the same while the customer map expands. In 2025, this low-capex route fits home-infusion selling, where local training and partner coverage can speed adoption.\u003c\/p\u003e\n\u003ctable class=\"tbl_prdct green_head blur_tbl\"\u003e\n\u003cthead\u003e\u003ctr\u003e\n\u003cth\u003e2025 signal\u003c\/th\u003e\n\u003cth\u003eMarket Development use\u003c\/th\u003e\n\u003c\/tr\u003e\u003c\/thead\u003e\n\u003ctbody\u003e\n\u003ctr\u003e\n\u003ctd\u003eSame systems\u003c\/td\u003e\n\u003ctd\u003eNew countries\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003ctr\u003e\n\u003ctd\u003eDistributor-led\u003c\/td\u003e\n\u003ctd\u003eLower entry cost\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003ctr\u003e\n\u003ctd\u003eLocalized training\u003c\/td\u003e\n\u003ctd\u003eFaster uptake\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003c\/tbody\u003e\n\u003c\/table\u003e\n\u003cbutton class=\"get_full_prdct_green\" onclick=\"get_full()\"\u003e\u003c\/button\u003e\n\u003c\/div\u003e\n\u003c\/section\u003e\n\u003c\/div\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"container_new_design\"\u003e\n\u003cdiv class=\"text-section text-1_new_design\"\u003e\n\u003ch2\u003e\n\u003cspan style=\"color: #3BB77E;\"\u003eFull Version Awaits\u003c\/span\u003e\u003cbr\u003eKORU Medical Systems, Inc. Reference Sources\u003c\/h2\u003e\n\u003cp\u003eThis is the actual Ansoff Matrix analysis document you’ll receive upon purchase—no surprises, just professional quality; the preview below is taken directly from the full report and the complete, editable version is unlocked after payment.\u003c\/p\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"image-section image-1_new_design\"\u003e\n\u003cimg src=\"\/cdn\/shop\/files\/GENERAL-Explore-Preview-Image.png\" alt=\"Explore a Preview\"\u003e\n\u003c\/div\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"pr-shrt-dscr-wrapper\"\u003e\n\u003cdiv class=\"container_new_design pr-shrt-dscr-box\"\u003e\n\u003cdiv class=\"text-section text-1_new_design\"\u003e\n\u003cdiv class=\"sub-highlight-wrapper_heading\"\u003e\n\u003cimg src=\"\/cdn\/shop\/files\/ANSOFF-Content-Product-Development-Icon-1.svg\" alt=\"Icon\"\u003e\n\u003ch2\u003eProduct Development\u003c\/h2\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"sub-highlight-wrapper\"\u003e\n\u003csection class=\"sub-highlight-box\"\u003e\n\u003cdiv class=\"sub-highlight-icon\"\u003e\n\u003cimg src=\"\/cdn\/shop\/files\/GENERAL-Checkmark-Icon.svg\" alt=\"Icon\"\u003e\n\u003ch3\u003eNext-generation FREEDOM infusion system variants\u003c\/h3\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"sub-highlight-content\"\u003e\n\u003cp\u003eNext-generation FREEDOM variants fit KORU Medical Systems, Inc.'s product development move by upgrading the existing platform for current users. The Company already sells 2 core syringe drivers, FREEDOM60 and FreedomEdge, so new models can reuse the same mechanical infusion base and lower changeover risk. This supports higher-value sales without starting from zero.\u003c\/p\u003e\n\u003c\/div\u003e\n\u003c\/section\u003e\n\u003csection class=\"sub-highlight-box\"\u003e\n\u003cdiv class=\"sub-highlight-icon\"\u003e\n\u003cimg src=\"\/cdn\/shop\/files\/GENERAL-Checkmark-Icon.svg\" alt=\"Icon\"\u003e\n\u003ch3\u003eExpanded HIgH-Flo needle set line\u003c\/h3\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"sub-highlight-content\"\u003e\n\u003cp\u003eExpanded HIgH-Flo needle sets are a line-extension move for KORU Medical Systems, Inc., building on an existing consumable and keeping the same subcutaneous delivery market. Adding sizes or configurations can lift repeat purchases from the installed base and improve recurring revenue without heavy new-market risk. In Ansoff terms, this is the lowest-risk growth path.\u003c\/p\u003e\n\u003c\/div\u003e\n\u003c\/section\u003e\n\u003c\/div\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"image-section image-1_new_design\"\u003e\n\u003cimg src=\"\/cdn\/shop\/files\/ANSOFF-Content-Product-Development-Image.png\" alt=\"Explore a Preview\"\u003e\n\u003c\/div\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"sub-highlight-box-border\"\u003e\n\u003csection class=\"sub-highlight-box\"\u003e\n\u003cdiv class=\"sub-highlight-icon\"\u003e\n\u003cimg src=\"\/cdn\/shop\/files\/GENERAL-Checkmark-Icon.svg\" alt=\"Icon\"\u003e\n\u003ch3\u003eRefined precision flow rate tubing offerings\u003c\/h3\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"sub-highlight-content\"\u003e\n\u003cp\u003eThis is product development because it upgrades KORU Medical Systems, Inc.'s existing precision flow rate tubing for current FREEDOM system users. Better compatibility, packaging, or SKU options can lift accessory pull-through without needing a new market. In 2025, this kind of line extension fits KORU's repeat-use model and supports higher retention per installed base.\u003c\/p\u003e\n\u003c\/div\u003e\n\u003c\/section\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"product-green-section\"\u003e\n\u003cdiv class=\"product-box-green-section4\"\u003e\n\u003cdiv class=\"title-row-green-section\"\u003e\n\u003ch3\u003eAccessory kits for FREEDOM60 and FreedomEdge\u003c\/h3\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"content-row-green-section blur_box\"\u003e\n\u003cp\u003eAccessory kits for FREEDOM60 and FreedomEdge fit KORU Medical Systems, Inc. in the product development quadrant because they add supporting items to an existing platform, not a new therapy. The base systems already depend on multiple components, so bundled kits can make setup simpler for providers and patients and raise per-treatment convenience.\u003c\/p\u003e\n\u003cp\u003eThis is a low-risk extension of an installed base used for subcutaneous immunoglobulin and other infusion workflows. By packaging needed parts together, KORU Medical Systems, Inc. can reduce missing-item delays and support repeat use without changing the core pump design.\u003c\/p\u003e\n\u003cul class=\"lst_crct\"\u003e\n\u003cli\u003eExtends current product lines\u003c\/li\u003e\n\u003cli\u003eUses existing system components\u003c\/li\u003e\n\u003cli\u003eImproves clinic and home convenience\u003c\/li\u003e\n\u003cli\u003eCan support repeat accessory sales\u003c\/li\u003e\n\u003c\/ul\u003e\n\u003c\/div\u003e\n\u003cbutton class=\"get_full_prdct_green\" onclick=\"get_full()\"\u003e\u003c\/button\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"product-box-green-section4\"\u003e\n\u003cdiv class=\"title-row-green-section\"\u003e\n\u003ch3\u003eExpanded education and training packages\u003c\/h3\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"content-row-green-section blur_box\"\u003e\n\u003cp\u003eExpanded education and training packages turn KORU Medical Systems, Inc. learning content into a paid product layer, not just support material. That fits the current portfolio well because KORU already trains 3 user groups: healthcare professionals, patients, and patient advocates.\u003c\/p\u003e\n\u003cp\u003eMore structured packages can speed adoption of the current infusion systems by reducing setup errors, improving confidence, and shortening time to first use. This is a low-capex way to deepen customer stickiness and can lift repeat orders without changing the core device.\u003c\/p\u003e\n\u003cp\u003eFor an Ansoff lens, this is product development with a clear service add-on: same customer base, richer offer, higher value per account. If KORU bundles device onboarding, refreshers, and role-based modules, it can make education a measurable revenue stream and a stronger moat.\u003c\/p\u003e\n\u003cul class=\"lst_crct\"\u003e\n\u003cli\u003eTurns training into a product.\u003c\/li\u003e\n\u003cli\u003eTargets 3 existing user groups.\u003c\/li\u003e\n\u003cli\u003eBoosts adoption of current devices.\u003c\/li\u003e\n\u003cli\u003eRaises stickiness without new hardware.\u003c\/li\u003e\n\u003c\/ul\u003e\n\u003c\/div\u003e\n\u003cbutton class=\"get_full_prdct_green\" onclick=\"get_full()\"\u003e\u003c\/button\u003e\n\u003c\/div\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"sub-highlight-box-border\"\u003e\n\u003csection class=\"highlight-box\"\u003e\n\u003cdiv class=\"highlight-icon\"\u003e\n\u003cimg src=\"\/cdn\/shop\/files\/GENERAL-Checkmark-Icon.svg\" alt=\"Icon\"\u003e\n\u003ch3\u003eKORU’s Upgrades Turn an Installed Base Into Repeat Sales\u003c\/h3\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"highlight-content\"\u003e\n\u003cp\u003eKORU Medical Systems, Inc. is in product development when it upgrades FREEDOM60, FreedomEdge, HIgH-Flo sets, and accessory kits for the same subcutaneous infusion base. This lifts repeat sales from an installed base of 3 user groups and keeps risk lower than new-market moves.\u003c\/p\u003e\n\u003ctable class=\"tbl_prdct green_head blur_tbl\"\u003e\n\u003cthead\u003e\u003ctr\u003e\n\u003cth\u003eMove\u003c\/th\u003e\n\u003cth\u003eWhy it fits\u003c\/th\u003e\n\u003cth\u003eValue\u003c\/th\u003e\n\u003c\/tr\u003e\u003c\/thead\u003e\n\u003ctbody\u003e\n\u003ctr\u003e\n\u003ctd\u003eNext-gen pumps\u003c\/td\u003e\n\u003ctd\u003eSame platform\u003c\/td\u003e\n\u003ctd\u003eHigher-value upgrades\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003ctr\u003e\n\u003ctd\u003eNeedle set extensions\u003c\/td\u003e\n\u003ctd\u003eSame market\u003c\/td\u003e\n\u003ctd\u003eMore repeat orders\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003ctr\u003e\n\u003ctd\u003eTraining packages\u003c\/td\u003e\n\u003ctd\u003eSame users\u003c\/td\u003e\n\u003ctd\u003eBetter adoption\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003c\/tbody\u003e\n\u003c\/table\u003e\n\u003cbutton class=\"get_full_prdct_green\" onclick=\"get_full()\"\u003e\u003c\/button\u003e\n\u003c\/div\u003e\n\u003c\/section\u003e\n\u003c\/div\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"pr-shrt-dscr-wrapper\"\u003e\n\u003cdiv class=\"container_new_design pr-shrt-dscr-box\"\u003e\n\u003cdiv class=\"text-section text-2_new_design\"\u003e\n\u003cdiv class=\"sub-highlight-wrapper_heading\"\u003e\n\u003cimg src=\"\/cdn\/shop\/files\/ANSOFF-Content-Diversification-Icon-1.svg\" alt=\"Icon\"\u003e\n\u003ch2\u003eDiversification\u003c\/h2\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"sub-highlight-wrapper\"\u003e\n\u003csection class=\"sub-highlight-box\"\u003e\n\u003cdiv class=\"sub-highlight-icon\"\u003e\n\u003cimg src=\"\/cdn\/shop\/files\/GENERAL-Checkmark-Icon.svg\" alt=\"Icon\"\u003e\n\u003ch3\u003ePatient-support education products for new buying centers\u003c\/h3\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"sub-highlight-content\"\u003e\n\u003cp\u003ePatient-support education products would let KORU Medical Systems, Inc. move past device sales and sell to hospitals, specialty pharmacies, and payers that buy training as a service. KORU already serves patients and advocates with education content, so packaging that know-how can create a new revenue stream with lower capital needs than hardware. If adoption lifts even a small slice of KORU Medical Systems, Inc.'s 2025 install base, the upside is meaningful.\u003c\/p\u003e\n\u003c\/div\u003e\n\u003c\/section\u003e\n\u003csection class=\"sub-highlight-box\"\u003e\n\u003cdiv class=\"sub-highlight-icon\"\u003e\n\u003cimg src=\"\/cdn\/shop\/files\/GENERAL-Checkmark-Icon.svg\" alt=\"Icon\"\u003e\n\u003ch3\u003eStandalone clinical training services\u003c\/h3\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"sub-highlight-content\"\u003e\n\u003cp\u003eStandalone clinical training services would let KORU Medical Systems, Inc. separate know-how from device sales and sell it into new markets. Because the company already has training materials and onboarding support, this is a low-friction adjacent move that can reach hospitals, home-infusion providers, and distributors that may not buy devices directly. It also creates a service revenue stream with lower capital needs than hardware expansion.\u003c\/p\u003e\n\u003c\/div\u003e\n\u003c\/section\u003e\n\u003c\/div\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"image-section image-2_new_design\"\u003e\n\u003cimg src=\"\/cdn\/shop\/files\/ANSOFF-Content-Diversification-Image.png\" alt=\"Explore a Preview\"\u003e\n\u003c\/div\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"sub-highlight-box-border\"\u003e\n\u003csection class=\"sub-highlight-box\"\u003e\n\u003cdiv class=\"sub-highlight-icon\"\u003e\n\u003cimg src=\"\/cdn\/shop\/files\/GENERAL-Checkmark-Icon.svg\" alt=\"Icon\"\u003e\n\u003ch3\u003eBroader infusion-adjacent consumables portfolio\u003c\/h3\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"sub-highlight-content\"\u003e\n\u003cp\u003eBroadening into infusion-adjacent consumables would move KORU Medical Systems, Inc. beyond syringe drivers, needle sets, and tubing into higher-repeat products that fit its existing device-and-consumables model. That makes diversification logical because the company already sells parts of the infusion workflow, so add-on accessories can lift share of wallet without a full platform reset.\u003c\/p\u003e\n\u003cp\u003eIt could also open more care settings, including hospitals, ambulatory centers, and home infusion, where accessories are replaced often and buying is recurring. This is the cleanest Ansoff step here: adjacent products, adjacent users, lower risk than a new core technology bet.\u003c\/p\u003e\n\u003c\/div\u003e\n\u003c\/section\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"product-green-section\"\u003e\n\u003cdiv class=\"product-box-green-section4\"\u003e\n\u003cdiv class=\"title-row-green-section\"\u003e\n\u003ch3\u003eTherapy-adjacent mechanical delivery applications\u003c\/h3\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"content-row-green-section blur_box\"\u003e\n\u003cp\u003eTherapy-adjacent mechanical delivery would stretch KORU Medical Systems, Inc.’s infusion know-how into new uses beyond ambulatory pumps, using the same mobile-device design base. In FY2025, the company’s net sales were about $36 million, so even small wins in adjacent channels could matter. A move into non-core delivery settings would diversify revenue without building a new platform from scratch.\u003c\/p\u003e\n\u003cul class=\"lst_crct\"\u003e\n\u003cli\u003eUses existing mechanical infusion expertise\u003c\/li\u003e\n\u003cli\u003eTargets new therapy-adjacent use cases\u003c\/li\u003e\n\u003cli\u003eDiversifies beyond ambulatory infusion\u003c\/li\u003e\n\u003cli\u003eFits a FY2025 revenue base near $36 million\u003c\/li\u003e\n\u003c\/ul\u003e\n\u003c\/div\u003e\n\u003cbutton class=\"get_full_prdct_green\" onclick=\"get_full()\"\u003e\u003c\/button\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"product-box-green-section4\"\u003e\n\u003cdiv class=\"title-row-green-section\"\u003e\n\u003ch3\u003eInternational service and support bundles\u003c\/h3\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"content-row-green-section blur_box\"\u003e\n\u003cp\u003eInternational service and support bundles fit KORU Medical Systems, Inc.’s diversification play: they pair new offerings with markets beyond its current base, while using the company’s existing international footprint. That shifts value from one-time device shipment revenue toward recurring service revenue, which can smooth sales volatility.\u003c\/p\u003e\n\u003cp\u003eThis matters because KORU already sells outside the U.S., so bundled training, maintenance, and clinical support can deepen account value without needing a new device launch.\u003c\/p\u003e\n\u003cul class=\"lst_crct\"\u003e\n\u003cli\u003eNew offer: recurring service bundle\u003c\/li\u003e\n\u003cli\u003eNew market: broader international accounts\u003c\/li\u003e\n\u003cli\u003eBenefit: less dependence on device shipments\u003c\/li\u003e\n\u003c\/ul\u003e\n\u003c\/div\u003e\n\u003cbutton class=\"get_full_prdct_green\" onclick=\"get_full()\"\u003e\u003c\/button\u003e\n\u003c\/div\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"sub-highlight-box-border\"\u003e\n\u003csection class=\"highlight-box\"\u003e\n\u003cdiv class=\"highlight-icon\"\u003e\n\u003cimg src=\"\/cdn\/shop\/files\/GENERAL-Checkmark-Icon.svg\" alt=\"Icon\"\u003e\n\u003ch3\u003eDiversification Could Lift KORU Beyond Device Sales\u003c\/h3\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"highlight-content\"\u003e\n\u003cp\u003eDiversification for KORU Medical Systems, Inc. means turning infusion know-how into new services and adjacent products, such as clinical training, support bundles, and consumables. With FY2025 net sales near $36 million, even small wins in new revenue streams can matter. These moves fit the current base and can reduce dependence on device shipments.\u003c\/p\u003e\n\u003ctable class=\"tbl_prdct green_head blur_tbl\"\u003e\n\u003cthead\u003e\u003ctr\u003e\n\u003cth\u003eMove\u003c\/th\u003e\n\u003cth\u003eWhy it fits\u003c\/th\u003e\n\u003cth\u003eFY2025 signal\u003c\/th\u003e\n\u003c\/tr\u003e\u003c\/thead\u003e\n\u003ctbody\u003e\n\u003ctr\u003e\n\u003ctd\u003eTraining services\u003c\/td\u003e\n\u003ctd\u003eUses existing support content\u003c\/td\u003e\n\u003ctd\u003eLow-capex new revenue\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003ctr\u003e\n\u003ctd\u003eConsumables\u003c\/td\u003e\n\u003ctd\u003eHigher repeat buying\u003c\/td\u003e\n\u003ctd\u003eFits device model\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003c\/tbody\u003e\n\u003c\/table\u003e\n\u003cbutton class=\"get_full_prdct_green\" onclick=\"get_full()\"\u003e\u003c\/button\u003e\n\u003c\/div\u003e\n\u003c\/section\u003e\n\u003c\/div\u003e\n\u003c\/div\u003e","brand":"DCF Analyst","offers":[{"title":"Default Title","offer_id":57234581487881,"sku":"krmd-ansoff-analysis","price":5.0,"currency_code":"USD","in_stock":true}],"thumbnail_url":"\/\/cdn.shopify.com\/s\/files\/1\/0942\/8045\/0313\/files\/krmd-ansoff-matrix.webp?v=1785723223","url":"https:\/\/dcfanalyst.com\/products\/krmd-ansoff-analysis","provider":"DCF Analyst","version":"1.0","type":"link"}